Philippe Moris

Randomized, Double‐Blind, Phase 2a Trial of Falciparum Malaria Vaccines RTS,S/AS01B and RTS,S/AS02A in Malaria‐Naive Adults: Safety, Efficacy, and Immunologic Associates of Protection

Kent E. Kester, James F. Cummings, Opokua Ofori‐Anyinam et al. · The Journal of Infectious Diseases · 2009 · 533 citations · Full text

Enhanced humoral and memory B cellular immunity using HPV16/18 L1 VLP vaccine formulated with the MPL/aluminium salt combination (AS04) compared to aluminium salt only

Sandro Giannini, Emmanuel Hanon, Philippe Moris et al. · Vaccine · 2006 · 495 citations

Vaccination, Mucosal Vaccination, Vaccine Development +12

Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers

Pierre Vandepapelière, Yves Horsmans, Philippe Moris et al. · Vaccine · 2008 · 220 citations

Vaccination, Healthy Adult Volunteers, Vaccine Development +12

H5N1 Influenza Vaccine Formulated with AS03A Induces Strong Cross-Reactive and Polyfunctional CD4 T-Cell Responses

Philippe Moris, Robbert van der Most, Isabel Leroux‐Roels et al. · Journal of Clinical Immunology · 2010 · 159 citations · Full text

Improved CD4+ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: A randomized trial

Isabel Leroux‐Roels, Sheron Forgus, Fien De Boever et al. · Vaccine · 2012 · 157 citations

Vaccination, Pulmonary Tuberculosis, Adaptive Immune System +9